XLRN

Acceleron Pharma
XLRN

Delisted

XLRN was delisted on the 19th of November, 2021.

137 hedge funds and large institutions have $1.66B invested in Acceleron Pharma in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

17% less call options, than puts

Call options by funds: $4.12M | Put options by funds: $4.95M

39% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 28

Holders
137
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.12M
Puts
$4.95M
Net Calls
Net Calls Change

Top Sellers

1 -$34.2M
2 -$16.6M
3 -$13.4M
4
Citadel Advisors
Citadel Advisors
Florida
-$6.48M
5
GTC
Ghost Tree Capital
New York
-$6.37M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$365K
102
$352K
103
$348K
104
$340K
105
$328K
106
$297K
107
$289K
108
$254K
109
$242K
110
$239K
111
$221K
112
$217K
113
$217K
114
$216K
115
$215K
116
$198K
117
$193K
118
$138K
119
$138K
120
$72.1K
121
$69K
122
$62K
123
$40K
124
$31K
125
$24K